title: Drug reaction with eosinophilia and systemic symptoms in metastatic basal cell carcinoma treated with vismodegib.
authors.affiliation: Skin and Cancer Foundation Australia.|University of Sydney.
authors.forename: Charlotte L
authors.identifier: http://orcid.org/0000-0003-1513-0927
authors.initials: CL
authors.lastname: Thomas
authors.affiliation: Department of Medical Oncology, Sydney Adventist Hospital.
authors.forename: Malmaruha
authors.initials: M
authors.lastname: Arasaratnam
authors.affiliation: Skin and Cancer Foundation Australia.|University of Sydney.|Department of Dermatology, Westmead Hospital.
authors.forename: Giuliana
authors.initials: G
authors.lastname: Carlos
authors.affiliation: Department of Surgical Oncology, Sydney Adventist Hospital, The University of Sydney.
authors.forename: Andrew
authors.initials: A
authors.lastname: Parasyn
authors.affiliation: Department of Immunology, Sydney Adventist Hospital, The University of Sydney.
authors.forename: Karl W
authors.initials: KW
authors.lastname: Baumgart
authors.affiliation: Skin and Cancer Foundation Australia.|University of Sydney.|Department of Dermatology, Westmead Hospital.
authors.forename: Pablo
authors.identifier: http://orcid.org/0000-0003-4882-1564
authors.initials: P
authors.lastname: Fernandez-Penas
authors.affiliation: University of Sydney.|Department of Medical Oncology, Sydney Adventist Hospital.
authors.forename: Gavin
authors.initials: G
authors.lastname: Marx
mesh_terms: D000368:Aged; D000813:Anilides / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D063926:Drug Hypersensitivity Syndrome / Q000209:etiology*; D006801:Humans; D008297:Male; D011725:Pyridines / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D011725:Pyridines